公开(公告)号：US08293917B2

公开(公告)日：2012-10-23

申请号：US12990248

申请日：2009-05-01

申请人： Brian Nicholas Cook ,  Christian Harcken ,  Thomas Wei-Ho Lee ,  Pingrong Liu ,  Jord Lord ,  Can Mao ,  Wang Mao ,  Brian Christopher Raudenbush ,  Hossein Razavi ,  Christopher Ronald Sarko ,  Alen David Swinamer

发明人： Brian Nicholas Cook ,  Christian Harcken ,  Thomas Wei-Ho Lee ,  Pingrong Liu ,  Jord Lord ,  Can Mao ,  Wang Mao ,  Brian Christopher Raudenbush ,  Hossein Razavi ,  Christopher Ronald Sarko ,  Alen David Swinamer

IPC分类号： C07D401/00 ,  A61K31/44

CPC分类号： C07D401/12 ,  C07D231/14 ,  C07D405/14 ,  C07D417/12

摘要： Disclosed are compounds of the formula (I) which block the interaction of CCR1 and its ligands and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

摘要翻译： 公开了式（I）的化合物，其阻断CCR1及其配体的相互作用，因此可用于治疗通过CCR1的活性介导或维持的多种疾病和病症，包括自身免疫疾病，例如类风湿性关节炎和多发性 硬化。 还公开了包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。